Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action

Neuron. 1993 Dec;11(6):1013-21. doi: 10.1016/0896-6273(93)90215-d.

Abstract

Sensitivity to dihydropyridines (DHPs) is a distinct characteristic that differentiates L-type Ca2+ channels from T-, N-, and P-type Ca2+ channels. To identify regions necessary for the functional effects of DHPs, chimeric Ca2+ channels were constructed in which portions of motif III or motif IV of a DHP-insensitive brain Ca2+ channel, BI-2, were introduced into the DHP-sensitive cardiac L-type Ca2+ channel. The resultant chimeric Ca2+ channels were expressed in Xenopus oocytes, and the effects of a DHP agonist and antagonist were studied. The results show that the linker region between S5 and S6 in motif IV of the L-type Ca2+ channel is a major site for DHP action. The DHP agonist and antagonist molecules interact with distinct sites on the alpha 1 subunit of the L-type Ca2+ channel. The data further show that the SS2-S6 region of motif III is not involved in DHP action but may be an important structural component of inactivation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Binding Sites
  • Brain / metabolism
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / chemistry*
  • Calcium Channels / drug effects
  • Calcium Channels / physiology*
  • Dihydropyridines / metabolism*
  • Dihydropyridines / pharmacology
  • Female
  • Macromolecular Substances
  • Molecular Sequence Data
  • Myocardium / metabolism
  • Oocytes / drug effects
  • Oocytes / physiology
  • Protein Structure, Secondary
  • Rabbits
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / drug effects
  • Recombinant Fusion Proteins / metabolism
  • Sequence Homology, Amino Acid
  • Xenopus

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Dihydropyridines
  • Macromolecular Substances
  • Recombinant Fusion Proteins